|
1
|
Patru CL, Surlin V, Georgescu I and Patru
E: Current issues in gastric cancer epidemiology. Rev Med Chir Soc
Med Nat Iasi. 117:199–204. 2013.PubMed/NCBI
|
|
2
|
Schmidt T, Alldinger I, Blank S, Klose J,
Springfeld C, Dreikhausen L, Weichert W, Grenacher L, Bruckner T,
Lordick F, et al: Surgery in oesophago-gastric cancer with
metastatic disease: Treatment, prognosis and preoperative patient
selection. Eur J Surg Oncol. 41:1340–1347. 2005. View Article : Google Scholar
|
|
3
|
Jeon EK, Hong SH, Kim TH, Jung SE, Park
JC, Won HS, Ko YH, Rho SY and Hong YS: Modified FOLFIRI as
second-line chemotherapy after failure of modified FOLFOX-4 in
advanced gastric cancer. Cancer Res Treat. 43:148–153. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yan Z, Zhang B, Huang Y, Qiu H, Chen P and
Guo GF: Involvement of autophagy inhibition in Brucea javanica oil
emulsion-induced colon cancer cell death. Oncol Lett. 9:1425–1431.
2015.PubMed/NCBI
|
|
5
|
Hu Y, Wan XJ, Pan LL, Zhang SH and Zheng
FY: Effects of Brucea javanica oil emulsion on human papilloma
virus type 16 infected cells and mechanisms research. Zhongguo
Zhong Xi Yi Jie He Za Zhi. 33:1545–1551. 2013.(In Chinese).
PubMed/NCBI
|
|
6
|
Ohtsu A, Ajani JA, Bai YX, Bang YJ, Chung
HC, Pan HM, Sahmoud T, Shen L, Yeh KH, Chin K, et al: Everolimus
for previously treated advanced gastric cancer: Results of the
randomized, double-blind, phase III GRANITE-1 study. J Clin Oncol.
31:3935–3943. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yamamoto D, Hamada Y, Okazaki S, Kawakami
K, Kanzaki S, Yamamoto C and Yamamoto M: Metastatic gastric tumor
from renal cell carcinoma. Gastric Cancer. 12:170–173. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chung HW, Lee SY, Han HS, Park HS, Yang
JH, Lee HH and So Y: Gastric cancers with microsatellite
instability exhibit high fluorodeoxyglucose uptake on positron
emission tomography. Gastric Cancer. 16:185–192. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wen J, Linghu EQ, Yang YS, Liu QS, Yang J
and Lu ZS: Associated risk factor analysis for positive resection
margins after endoscopic submucosal dissection in early-stage
gastric cancer. J BUON. 20:421–427. 2015.PubMed/NCBI
|
|
10
|
He YX, Song XH, Zhao ZY and Zhao H: HOXA13
upregulation in gastric cancer is associated with enhanced cancer
cell invasion and epithelial-to-mesenchymal transition. Eur Rev Med
Pharmacol Sci. 21:258–265. 2017.PubMed/NCBI
|
|
11
|
Ye M, Jin K, Xu G, Lin F, Zhou Q, Tao K
and Tao F: Short-and long-term outcomes after conversion of
laparoscopic total gastrectomy for gastric cancer: A single-center
study. J BUON. 22:126–133. 2017.PubMed/NCBI
|
|
12
|
Chung HW, Lee SY, Han HS, Park HS, Yang
JH, Lee HH and So Y: Gastric cancers with microsatellite
instability exhibit high fluorodeoxyglucose uptake on positron
emission tomography. Gastric Cancer. 16:185–192. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wen J, Linghu EQ, Yang YS, Liu QS, Yang J
and Lu ZS: Associated risk factor analysis for positive resection
margins after endoscopic submucosal dissection in early-stage
gastric cancer. J BUON. 20:421–427. 2015.PubMed/NCBI
|
|
14
|
He YX, Song XH, Zhao ZY and Zhao H: HOXA13
upregulation in gastric cancer is associated with enhanced cancer
cell invasion and epithelial-to-mesenchymal transition. Eur Rev Med
Pharmacol Sci. 21:258–265. 2017.PubMed/NCBI
|
|
15
|
Wu YC, Zhang YC, Dai GX, Wang LJ and
Jin-Kea YE: Clinical observation of Bruceolic oil emulsion combined
with FOLFOX4 in treating advanced carcinoma of stomach. Med Pharm J
Chin Peoples Liberation Army. 24:29–31. 2012.(In Chinese).
|
|
16
|
Xu W, Jiang X, Xu Z, Ye T and Shi Q: The
efficacy of Brucea javanica oil emulsion injection as adjunctive
therapy for advanced non-small-cell lung cancer: A meta-analysis.
Evid Based Complement Alternat Med. 2016:59285622016. View Article : Google Scholar : PubMed/NCBI
|
